Exogenous IL-13 exacerbates Leishmania major infection and abrogates acquired immunity to re-infection
- 10 May 2022
- journal article
- research article
- Published by Springer Nature in Parasitology Research
- Vol. 121 (7) , 2009-2017
Abstract
Cutaneous leishmaniasis is a major global health issue, affecting more than 88 countries with 0.7–1.2 million new cases per year. T helper polarization plays a significant role in disease outcome, with Th1 responses being associated with resistance and Th2 responses being associated with susceptibility. IL-13 is an important Th2 cytokine with structural and functional similarities to IL-4. In this study, we demonstrate that administering exogenous IL-13 to Leishmania major-infected BALB/c mice increases parasite load in the infected paw and decreases tissue levels of the key Th1/Th2 cytokines IFN-γ and IL-4, respectively. Infecting BALB/c mice with a low dose of L. major has previously been shown to confer resistance to re-infection with a higher dose. In this study, we demonstrate that administration of exogenous IL-13 early in the course of the initial low-dose infection abrogates acquired resistance to high-dose re-infection, as measured by infected paw thickness.Keywords
This publication has 19 references indexed in Scilit:
- In Leishmania major-induced inflammation, interleukin-13 reduces hyperalgesia, down-regulates IL-1β and up-regulates IL-6 in an IL-4 independent mechanism1This project was mainly funded by the Balamand Research Grant.1Experimental Parasitology, 2013
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- T Helper1/T Helper2 Cells and Resistance/Susceptibility to Leishmania Infection: Is This Paradigm Still Relevant?Frontiers in Immunology, 2012
- Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin – than on footpad-infected miceExperimental Parasitology, 2012
- Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 miceMemórias do Instituto Oswaldo Cruz, 2007
- The wound repair response controls outcome to cutaneous leishmaniasisProceedings of the National Academy of Sciences, 2005
- Requirements for Th1-dependent immunity against infection with Leishmania majorMicrobes and Infection, 2004
- The Primary Binding Subunit of the Human Interleukin-4 Receptor Is Also a Component of the Interleukin-13 ReceptorJournal of Biological Chemistry, 1995
- Establishment of Stable, Cell-Mediated Immunity that Makes "Susceptible" Mice Resistant to Leishmania majorScience, 1992
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983